 Re: Are these any good?
Prazosin = quinazoline derivative.
Quinidine is an antimalarial schizonticide and an antiarrhythmic agent with Class Ia activity; it is the d-isomer of quinine, and its molecular weight is 324.43. Quinidine gluconate is the gluconate salt of quinidine; its chemical name is cinchonan-9-ol, 6'-methoxy-, (9S)-, mono-D-gluconate.
Its empirical formula is C20H24N2O2.C6H12O7, and its molecular weight is 520.58, of which 62.3% is quinidine base.
Each QUINAGLUTE DURA-TABS� tablet contains 324 mg of quinidine gluconate (202 mg of quinidine base) in a matrix to provide extended-release; the inactive ingredients include confectioner's sugar, magnesium stearate, corn starch and other ingredients. Meets USP Drug Release Test 4.
Guaifenesin = Expectorant.
Reduces chest congestion.
Guaifenesin (glyceryl guaiacolate) has the chemical name 3-(2- methoxyphenoxy)-1,2-propanediol. Its molecular formula is C10H14O4 with a molecular weight of 198.21. It is a white or slightly gray crystalline substance with a slightly bitter aromatic taste. One gram dissolves in 20 mL water at 25� C; it is freely soluble in ethanol. Guaifenesin is readily absorbed from the GI tract and is rapidly metabolized and excreted in the urine. Guaifenesin has a plasma half- life of one hour. The major urinary metabolite is b-(2-methoxyphenoxy) lactic acid.
Klor-Con 8 = Potassium Replacement.
Potassium chloride extended-release capsules, USP are a solid oral dosage form of potasium chloride containing 10 mEq (750 mg) of potassium chloride [equivalent to 10 mEq (390 mg) of potassium and 10 mEq (360 mg) of chloride] in a microencapsulated capsule. This formulation is intended to the release of potassium so that the likelihood of a high localized concentration of potassium chloride within the gastrointestinal tract is reduced.
Potassium chloride extended-release capsules are an electrolyte replenisher. The chemical name is potassium chloride, and the structural formula is KCl. Potassium chloride, USP occurs as a white, granular powder or as colorless crystals. It is odorless and has a saline taste. Its solutions are neutral to litmus. It is freely soluble in water and insoluble in alcohol.
Inactive ingredients: Calcium stearate, gelatin, pharmaceutical glaze, povidone, sugar spheres, talc.
Klor-Con Extended-release Tablets, USP are a solid oral dosage form of potassium chloride. Each contains 600 or 750 mg of potassium chloride equivalent to 8mEq or 10mEq of potassium in a wax matrix tablet.
Extended-Release Formulation for Liquid Suspension
Potassium chloride liquid suspension is an oral dosage form of microencapsulated potassium chloride. Each packet contains 1.5 g of potassium chloride, USP equivalent to 20 mEq of potassium. Potassium chloride liquid suspension is comprised of specially formulated granules. After reconstituting with 2-6 fly o of water and 1 minute of stirring, the suspension is odorless and tasteless.
Each crystal of potassium chloride (KCl) is microencapsulated with an insoluble polymeric coating which functions as a semipermeable membrane; it allows for the controlled release of potassium and chloride ions over an eight-ten hour period. The controlled release of K+ ions by the microcapsular membrane is intended to reduce the likelihood of a high localized concentration of potassium chloride at any point on the mucosa of the gastrointestinal tract. Fluids pass through the membrane and gradually dissolve the potassium chloride within the microcapsules. The resulting potassium chloride solution slowly diffuses outward through the membrane.
Potassium chloride liquid suspension is an electrolyte replenisher. The chemical name of the active ingredient is potassium chloride and the structural formula is KCl. Potassium Chloride, USP occurs as a white, granular powder or as colorless crystals. It is odorless and has a saline taste. Its solutions are neutral to litmus. It is freely soluble in water and insoluble in alcohol.
Inactive Ingredients: Docusate Sodium, Ethylcellulose, Povidone, Silicon Dioxide, Sucrose, and another ingredient.
Metaprolol = CARDIAC DRUG.
Metoprolol tartrate, is a selective beta1-adrenoreceptor blocking agent, available as 50- and 100-mg tablets for oral administration and in 5-ml ampuls for intravenous administration. Each ampul contains a sterile solution of metoprolol tartrate, 5 mg and sodium chloride, 45 mg. Metoprolol tartrate is (�)-1-(isopropylamino)-3-(p-(2-(methoxyethyl) phenoxy)-2-propanol (2:1) dextro-tartrate salt.
Metoprolol tartrate is a white, practically odorless, crystalline powder with a molecular weight of 684.82. It is very soluble in water; freely soluble in methylene chloride, in chloroform, and in alcohol; slightly soluble in acetone; and insoluble in ether.
Lopressor Inactive Ingredients: Tablets contain cellulose compounds, colloidal silicon dioxide, D&C red no. 30 aluminum lake (50-mg tablets), FD&C blue no. 2 aluminum lake (100-mg tablets), lactose, magnesium stearate, polyethylene glycol, propylene glycol, povidone, sodium starch glycolate, talc, and titanium dioxide.
Premarin = Estrogens.
Conjugated estrogens is a mixture of estrogens obtained exclusively from natural sources, occurring as the sodium salts of water-soluble estrogen sulfates blended to represent the average composition of material derived from pregnant mares' urine. It contains estrone, equilin, and 17 a-dihydroequilin, together with smaller amounts of 17 a-estradiol, equilenin, and 17 a-dihydroequilenin as salts of their sulfate esters.
Tablets
Tablets for oral administration are available in 0.3 mg, 0.625 mg, 0.9 mg, 1.25 mg, and 2.5 mg strengths of conjugated estrogens.
Premarin Tablets Contain the Following Inactive Ingredients: Calcium phosphate tribasic, calcium sulfate anhydrous (white tablet), calcium sulfate, carnauba wax, cellulose, glyceryl monooleate, lactose, magnesium stearate, methylcellulose, pharmaceutical glaze, polyethylene glycol, stearic acid, sucrose, talc, titanium dioxide.
0.3 mg Tablets Also Contain: D&C yellow no. 10, FD&C blue no. 1, FD&C blue no. 2, FD&C yellow no. 6;
0.625 mg Tablets Also Contain: FD&C blue no. 2, D&C red no. 27, FD&C red no. 40;
0.9 mg Tablets Also Contain: D&C red no. 6, D&C red no. 7;
1.25 mg Tablets Also Contain: Black iron oxide, D&C yellow no. 10, FD&C yellow no. 6;
2.5 mg Tablets Also Contain: FD&C blue no. 2, D&C red no. 7.
Injection
Each Secule vial contains 25 mg of conjugated estrogens, in a sterile lyophilized cake which also contains lactose 200 mg, sodium citrate 12.2 mg, and simethicone 0.2 mg. The pH is adjusted with sodium hydroxide or hydrochloric acid. A sterile diluent (5 ml) containing 2% benzyl alcohol in sterile water is provided for reconstitution. The reconstituted solution is suitable for intravenous or intramuscular injection.
Vaginal Cream
Each gram of Premarin (conjugated estrogens) Vaginal Cream contains 0.625 mg conjugated estrogens, in a nonliquefying base containing cetyl esters wax, cetyl alcohol, white wax, glyceryl monostearate, propylene glycol monostearate, methyl stearate, benzyl alcohol, sodium lauryl sulfate, glycerin, and mineral oil. Premarin Vaginal Cream is applied intravaginally.
Rythmol = ANTIARRHYTHMICS.
RYTHMOL (propafenone hydrochloride) is an antiarrhythmic drug supplied in scored, film-coated tablets of 150, 225 and 300 mg for oral administration. Propafenone has some structural similarities to beta-blocking agents.
The chemical formula of propafenone hydrochloride is: 2�-[2-Hydroxy-3-(propylamino)-propoxyl- 3-phenylpropiophenone hydrochloride. The molecular formula of propafenone hydrochloride is: C21H27NO3 � HCl and its molecular weight is 377.92.
Propafenone hydrochloride occurs as colorless crystals or white crystalline powder with a very bitter taste. It is slightly soluble in water (20� C), chloroform and ethanol.
The following inactive ingredients are contained in the tablet: corn starch, hydroxypropyl methylcellulose, magnesium stearate, polyethylene glycol, polysorbate, povidone, propylene glycol, sodium starch glycolate and titanium dioxide.
Diltiazem = CARDIAC DRUGS.
Diltiazem HCl is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem HCL is 1,5-benzothiazepin-4(5H)one, 3- (acetyloxy)-5-[2-( dimethylamino) ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride, (+)-cis-.
Diltiazem hydrochloride is a white to off-white crystalline powder with a bitter taste. It is soluble in water, methanol, and chloroform. It has a molecular weight of 450.98.
Cardizem Direct Compression Tablets: Each tablet contains 30 mg, 60 mg, 90 mg, or 120 mg diltiazem hydrochloride. Also contains: D&C yellow #10 aluminum lake, FD&C yellow #6 aluminum lake (60 mg and 120 mg), or FD&C blue #1 aluminum lake (30 mg and 90 mg), hydroxypropyl methylcellulose, lactose, magnesium stearate, methylparaben, microcrystalline cellulose, silicon dioxide, and other ingredients.
For oral administration.
Cardizem CD Capsules: Cardizem CD is formulated as a once-a-day extended release capsule containing either 120 mg, 180 mg, 240 mg, or 300 mg diltiazem hydrochloride. Also contains: Black iron oxide, ethylcellulose, FD&C blue #1, fumaric acid, gelatin-NF, sucrose, starch, talc, titanium dioxide, white wax and other ingredients.
For oral administration.
Cardizem SR Capsules: Each capsule contains either 60 mg, 90 mg, or 120 mg diltiazem hydrochloride. Also contains: D&C yellow #10, FD&C blue #1, FD&C red #40, FD&C yellow #6, fumaric acid, povidone, starch, sucrose, talc, titanium dioxide, and other ingredients.
For oral administration.
Cardizem Injectable: Cardizem Injectable is a clear, colorless, sterile, nonpyrogenic solution. It has a pH range of 3.7 to 4.1.
Cardizem injectable is for direct intravenous bolus injection and continuous intravenous infusion. 25-mg, 5-ml vial: Each sterile vial contains 25 mg diltiazem hydrochloride, 3.75 mg citric acid USP, 3.25 mg sodium citrate dihydrate, 357 mg sorbitol solution, and water for injection up to 5 ml. Sodium hydroxide or hydrochloric acid is used for pH adjustment. 50-mg, 10-ml vial: Each sterile vial contains 50 mg diltiazem hydrochloride, 7.5 mg citric acid USP, 6.5 mg sodium citrate dihydrate, 714 mg sorbitol solution, and water for injection up to 10 ml. Sodium hydroxide or hydrochloric acid is used for pH adjustment.
Cardizem Lyo-Ject Syringe: Cardizem Lyo-Ject Syringe after reconstitution contains a clear, colorless, sterile nonpyrogenic solution. It has a pH range of 4.0 to 7.0.
Cardizem Lyo-Ject Syringe after reconstitution is for direct intravenous bolus injection and continuous intravenous infusion.
Cardizem Lyo-Ject Syringe 25-mg syringe is available in a dual chamber, disposable syringe. Chamber 1 contains lyophilized powder comprised of diltiazem hydrochloride 25 mg and mannitol 37.5 mg. Chamber 2 contains sterile diluent composed of 5 ml water for injection with 0.5% benzyl alcohol NF, and 0.6% sodium chloride USP.
Cardizem Monovial: Cardizem Monovial, after reconstitution in an infusion bag, produces a clear, colorless, sterile, nonpyrogenic solution.
Cardizem Monovial for continuous intravenous infusion is available in a glass vial with transfer needle set. The vial contains lyophilized powder comprised of diltiazem hydrochloride 100 mg and mannitol 75 mg.
Singuilair = PROPHYLAXIS/TREATMENT CHRONIC PEDIATRIC ASTHMA.
Montelukast sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.
Montelukast sodium is described chemically as [R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid, monosodium salt.
The empirical formula is C35H35ClNNaO3S, and its molecular weight is 608.18.
Montelukast sodium is a hygroscopic, optically active, white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile.
Each 10-mg film-coated Singulair tablet contains 10.4 mg montelukast sodium, which is the molar equivalent to 10.0 mg of free acid, and the following inactive ingredients: microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, hydroxypropyl cellulose, and magnesium stearate. The film coating consists of: hydroxypropyl methylcellulose, hydroxypropyl cellulose, titanium dioxide, red iron oxide, yellow iron oxide, and carnauba wax.
Each 5-mg chewable Singulair tablet contains 5.2 mg montelukast sodium, which is the molar equivalent to 5.0 mg of free acid, and the following inactive ingredients: mannitol, microcrystalline cellulose, hydroxypropyl cellulose, red ferric oxide, croscarmellose sodium, cherry flavor, aspartame, and magnesium stearate.
In conclusion, none of these will get you high. All of this was found on rxlist in under five minutes BTW.
Also, you are stealing meds from a woman with heart problems, athsma, hormone problems and a potassium defeciency. Whom I would guess is your mother, why?
|
2002-12-09, 21:55
